Background: Having access to diabetes medication is essential for improving the health and quality of life of those living with diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and it can lead to serious complications if not managed properly.

Medication plays an important role in diabetes treatment, helping patients maintain healthy blood sugar levels and avoid potentially dangerous diabetes-related conditions such as heart disease, stroke, kidney failure, nerve damage, amputations, blindness, and more. Accessing appropriate diabetic medication can help reduce these risks and improve overall physical health for individuals living with diabetes.

Additionally, having access to diabetes medication allows for improved mental wellness by decreasing stress associated with managing their condition on a daily basis. Moreover, this access may also facilitate better economic outcomes due to reduced medical costs over time. Therefore, ensuring reliable access to diabetes medications has far-reaching implications in terms of both physical well-being as well as financial stability.

Objective: To lower patient A1c levels to under 9 by providing free access to free diabetic medications and delivery to patients’ home.

Methods: Hope Clinic of Garland patients with an A1c over 9 were enrolled in the joint study. This enabled their medical doctor to collect participant A1c labs every 3 months and chart progress into a shared database. With careful monitoring, we tracked any changes over time and improved insights on potential health outcomes.

Results: The joint study conducted by St. Vincent de Paul Pharmacy and Hope Clinic of Garland revealed that overall diabetes patients who received free access to their diabetic medication lowered their A1c to under 9 (95%).

Conclusion: The joint study provided a lifeline for people living with diabetes, and its success can be clearly seen in the drop in A1c levels achieved since the program’s implementation. These results highlight the lifesaving benefits that health equity initiatives can provide and underscore the importance of continued support and investment in health equity programs.


St. Vincent de Paul Pharmacy helps to bridge the healthcare gap between those with health insurance and those without, ensuring that everyone has the same opportunity for health and well-being regardless of income or insurance status.

Free access to medication for the uninsured is an essential part of health equity. This joint study between Hope Clinic of Garland and St. Vincent de Paul Pharmacy provides free access to diabetic medications to those without health insurance, allowing them to better manage their health and reduce the health risks associated with high blood sugar. This initiative provides free access to diabetic medications and delivery, with the goal of reducing patients’ A1c levels to under 9.

A1C Performance at Hope Clinic of Garland
A1C Performance at Hope Clinic of Garland

Conclusion: The joint study for diabetes patients has had remarkable results, as evidenced by its ability to reduce the overall average of A1c levels to below 9 in many cases. Studies have shown that when access to necessary care is improved, health outcomes for diabetes patients improve dramatically.